On-Demand Webinar: The Case for MeMed BV: Antimicrobial Resistance and Antimicrobial Stewardship with Kevin Garey, PharmD, MS, FASHP,
University of Houston College of Pharmacy. Watch here!

MeMed home headline.png

To treat or not to treat?
Millions of decisions a day.  Let's make them better.

MeMed BV.png

MeMed BV is a pioneering test for distinguishing between bacterial and viral infections that relies on the most accurate detection system - the body's immune system. MeMed BV aims to support physicians in making better informed antibiotic treatment decisions and tackling antimicrobial resistance - one of the biggest healthcare challenges of our time.

The test: MeMed BV

 

We are applying machine learning and artificial intelligence to the complex signaling of the world's most accurate diagnostic system, the immune system. Our pipeline of AI-based diagnostics addresses key clinical and medical challenges in infectious diseases and inflammatory disorders.

The platform: MeMed Key

MeMed Key is a first of its kind immunoassay platform, that opens the way to measuring multiple proteins with central lab performance at the point-of-need. Key will deliver MeMed BV test results in 15 minutes.

key for homepage2.png
Cartridge by itself.png
 
 

The evidence: Data is king

Our technology and products have been developed and rigorously validated in large multinational clinical studies encompassing thousands of patients and published in high impact scientific and medical journals.